Balanced Fluids for Pediatric Sepsis
(PRoMPT BOLUS Trial)
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It focuses on fluid resuscitation for septic shock in children.
Research suggests that using balanced fluids like Lactated Ringer's or Plasma-Lyte instead of normal saline may improve outcomes for sepsis patients, as they are associated with fewer complications like kidney injury and metabolic acidosis (a condition where the body produces too much acid). These balanced solutions may lead to better recovery in children with sepsis.
12345Research shows that balanced fluids like Lactated Ringer's and Plasma-Lyte are generally safe for use in humans, with stable vital signs and no significant adverse effects reported in studies involving healthy volunteers and children undergoing surgery.
26789Balanced fluids like Lactated Ringer's and Plasma-Lyte are different from normal saline because they are designed to more closely match the body's natural fluid composition, which may lead to better outcomes in pediatric sepsis by reducing risks like kidney injury and metabolic imbalances.
12345Eligibility Criteria
This trial is for children aged over 2 months and under 18 years with a physician's diagnosis of septic shock needing antibiotics and fluid resuscitation. It excludes those with certain metabolic disorders, known pregnancy, prisoners, allergies to crystalloid fluids, severe liver or kidney issues, high potassium or calcium levels, or if the clinician deems it unsafe.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either balanced fluids (BF) or 0.9% normal saline (NS) for fluid resuscitation immediately after randomization through the next calendar day
Follow-up
Participants are monitored for safety and effectiveness after treatment, with primary endpoint being major adverse kidney events within 30 days
Extended Follow-up
Participants are monitored for additional outcomes such as all-cause mortality at 90 days
Participant Groups
Lactated Ringer is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries
- fluid resuscitation after blood loss due to trauma or surgery
- sepsis
- acute pancreatitis
- burn injuries